In a separate comprehensive review, Ghoran and Kijjoa systematically catalog marine-derived compounds targeting AD by inhibiting enzymes such as AChE, BuChE, BACE-1, and various kinases, and by modulating Aβ aggregation pathways [67]. This evidence concerns the gene BACE1 and Alzheimer disease.